| Name | Title | Contact Details |
|---|
Occlutech was founded in Germany in 2003, and has since developed into one of the world´s leading suppliers in the area of structural heart disease with products and projects for; congenital defects, stroke prevention, and heart failure.
At Mitsubishi Tanabe Pharma America (MTPA), we believe in helping people who are struggling with serious and debilitating diseases.
R2P creates a unique physical therapy experience, offering our blend of performance, return to sport, physical therapy, dry needling and injury prevention.
Bristol Meyers Squibb Company is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome, diabetes, obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH).